Hydralazine Hydrochloride

A niche API used in its finished form (injectable) for production of local or regional anesthesia or analgesia for surgery, for oral surgery procedures, for diagnostic and therapeutic procedures, and for obstetrical procedures Available for all global markets along with DMF support.

A niche API used in its finished form (injectable) to administer local anesthesia, regional anesthesia, or surgical anesthesia.. Available for all global markets along with DMF support.

A niche API used in its finished form (tablet and injectable) for the treatment of parkinsonism or Parkinson's disease, including tremor due to the disease, drug-induced extrapyramidal symptoms and chronic sialorrhea (chronic drooling) in developmentally-disabled patients. Available for all global market...

A niche API used in its finished form (capsule) is an anti-rheumatic drug used to treat patients with active rheumatoid arthritis. It also is classified as a metal binding (chelating) agent used for treating Wilson's disease, Available for all global markets except the US along with DMF support.

A niche API used in its finished form (capsule) is used as an alpha blocker indicated for the treatment of high blood pressure and heavy sweating due to a certain tumor of the adrenal glands (pheochromocytoma). Available for all global markets along with DMF support.

A niche API used in its finished form (injectable) is used as a calcium channel blocker indicated for the short-term treatment of hypertension when oral therapy is not feasible or not desirable. Available for all global markets along with DMF support.

A niche API used in its finished form (tablet) indicated as an adjunct to diet and exercise to reduce elevated low-density lipoprotein cholesterol (LDL-C) in adults with primary hyperlipidemia (Fredrickson Type IIa) as monotherapy or in combination with a hydroxymethyl-glutaryl-coenzyme A (HMG CoA) redu...

A niche API used in its finished form (tablet) indicated as an adjunctive therapy to diet for the reduction of elevated serum total and LDL-C in patients with primary hypercholesterolemia (elevated LDL-C) who do not respond adequately to diet. Available for all global markets except the US and Europe al...

A niche API used in its finished form (injectable) indicated for the treatment of iron deficiency anemia. It is used in patients with kidney disease who are receiving dialysis. Available for all global markets except the US along with DMF support.

A niche API used in its finished form (injectable and tablet) indicated for the treatment of vitamin K1 deficiency, and to treat certain bleeding or blood-clotting problems caused by other medicines or medical conditions. Oral grade available for all global markets along with DMF support and injectable...

A niche API from our Iron product portfolio used in its finished form (injectable) indicated for iron deficiency anemia.  Available for all global markets along with DMF support.

A niche API used in its finished form (injectable) indicated for prophylaxis or treatment of thrombosis in adult patients with heparin-induced thrombocytopenia.  Available for all global markets along with DMF support.